Cytokinetics, Incorporated · NASDAQ:CYTK

FMR LLC reported a 9.40% stake in Cytokinetics, Incorporated (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 12, 2025

FMR LLC reported a 9.40% stake in Cytokinetics, Incorporated, 11,146,954 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).

Stake
9.40%
Shares
11,146,954
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC9.40%11,146,954
Abigail P. Johnson9.40%11,146,954

Source

View original at SEC

Related